Cuong V. Nguyen

Cuong V. Nguyen

Auto-generated profile, based on publicly available information

Cuong V. Nguyen

Department of Dermatology Northwestern University Feinberg School of Medicine Chicago Illinois USA

Research Focus & Metrics

Academic Career Length

23Years (2004-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
2 November 2023 in npj Regenerative Medicine
Verified
Journal Article
Open access
PDF file
DBDauren Biyashev
Dauren Biyashev
ZSZofia E. Siwicka
Zofia E. Siwicka
UOUmmiye V. Onay
Ummiye V. Onay
MDMichael Demczuk
Michael Demczuk
DXDan Xu
Dan Xu
KLKurt Q. Lu
Kurt Q. Lu
In acute skin injury, healing is impaired by the excessive release of reactive oxygen species (ROS). Melanin, an efficient scavenger of radical species in the skin, performs a key role in ROS scavenging in response to UV radiation and is upregulated in response to toxic insult. In a chemical injury model in mice, we demonstrate that the topical application of synthetic melanin particles (SMPs) significantly decreases edema, reduces eschar detachment time, and increases the rate of wound area reduction compared to vehicle controls. Furthermore, these results were replicated in a UV-injury model. Immune array analysis shows downregulated gene expression in apoptotic and inflammatory signaling pathways consistent with histological reduction in apoptosis. Mechanistically, synthetic melanin intervention increases superoxide dismutase (SOD) activity, decreases Mmp9 expression, and suppresses ERK1/2 phosphorylation. Furthermore, we observed that the application of SMPs caused increased populations of anti-inflammatory immune cells to accumulate in the skin, mirroring their decrease from splenic populations. To enhance antioxidant capacity, an engineered biomimetic High Surface Area SMP was deployed, exhibiting increased wound healing efficiency. Finally, in human skin explants, SMP intervention significantly decreased the damage caused by chemical injury. Therefore, SMPs are promising and effective candidates as topical therapies for accelerated wound healing, including via pathways validated in human skin.

1 April 2004 in Molecular Endocrinology
Verified
Journal Article
Open access
AIAyesha Ismail
Ayesha Ismail
CNCuong V. Nguyen
Cuong V. Nguyen
AAAgo Ahene
Ago Ahene
JFJames C Fleet
James C Fleet
MUMilan R. Uskokovic
Milan R. Uskokovic
SPSmadar Peleg
Smadar Peleg
The vitamin D analog, 1alpha-fluoro-16-ene-20-epi-23-ene-26,27-bishomo-25-hydroxyvitamin D(3) (Ro-26-9228) is tissue selective, with a gene regulation preference for bone over duodenum in vivo. In the human osteoblast-like cells, hFOB, the vitamin D receptor (VDR)-mediated transcriptional potencies of Ro-26-9228 and 1,25-dihydroxyvitamin D(3) (1,25D(3)) were similar, but in the intestinal cells, Caco-2, transcriptional potency of Ro-26-9228 was 10-50 times lower. We hypothesized that transcriptional activation of the VDR by Ro-26-9228 in the two cell types is regulated differently, and compared VDR extracted from hFOB or Caco-2 cells for their abilities to interact with a p160 coactivator [glucocorticoid receptor-interacting protein (GRIP)] and with retinoid X receptor (RXR) by pull-down assays. 1,25D(3) had similar potencies to induce interactions of VDR from the two cell types with these partners of transcription. In contrast, Ro-26-9228 induced interaction of osteoblastic VDR with RXR and GRIP but did not induce these interactions with VDR from Caco-2 cells. Further studies revealed that in hFOB cells the unoccupied VDR was cytoplasmic and proteasome sensitive, and that ligand treatment caused a rapid accumulation of the VDR in the chromatin. Both cytoplasmic and chromatin-associated ligand-bound VDR from hFOB cells had the abilities to interact with GRIP. In contrast, in Caco-2 cells, unoccupied VDR was localized in both the cytoplasm (70%) and the chromatin (30%). In Caco-2 cells, the cytoplasmic VDR was proteasome resistant, and neither 1,25D(3) nor Ro-26-9228 induced its binding to GRIP. Only a small fraction of the chromatin-associated VDR was proteasome sensitive, and this fraction was distinguishable by a faster electrophoretic mobility. 1,25D(3) induced an accumulation of the proteasome-sensitive VDR in the chromatin of Caco-2 cells and binding to GRIP. Ro-26-9228 failed to induce accumulation of the proteasome-sensitive VDR in the chromatin or binding to GRIP, but a coincubation of Caco-2 cells with the analog and a proteasome inhibitor restored these abilities. These results suggest that Ro-26-9228 has poor ability to promote the accumulation of a proteasome-sensitive, transcriptionally active VDR isoform in Caco-2 cells, whereas it does not have this limitation in hFOB cells.

20 January 2020 in Pediatric Dermatology
Verified
Journal Article
Closed access
PDF file
CNCuong V. Nguyen
Cuong V. Nguyen
SCSigrid Collier
Sigrid Collier
AMAshley H. Merten
Ashley H. Merten
SMSheilagh M. Maguiness
Sheilagh M. Maguiness
KHKristen P. Hook
Kristen P. Hook

1 November 2022 in Archives of Dermatological Research
Verified
Journal Article
Closed access
PDF file
PGParul Kathuria Goyal
Parul Kathuria Goyal
TMTaha O. Mohammed
Taha O. Mohammed
AMAli Mahmoud
Ali Mahmoud
AZAbu Jaafar Zaidi
Abu Jaafar Zaidi
CNCuong V. Nguyen
Cuong V. Nguyen

1 February 2023 in JAMA Dermatology
Verified
Journal Article
Open access
PDF file
CNCuong V. Nguyen
Cuong V. Nguyen
LZLida Zheng
Lida Zheng
XZXiaolong A. Zhou
Xiaolong A. Zhou
MEMadison K. Ernst
Madison K. Ernst
YKYae Kye
Yae Kye
KLKurt Q. Lu
Kurt Q. Lu
Toxic erythema of chemotherapy (TEC) is a unifying term for the broad spectrum of cutaneous dose-dependent cytotoxic reactions that may occur with receipt of chemotherapeutic agents.1 In acute cases of TEC, patients can develop severe erythema, pain, swelling, and/or blistering, which may require inpatient management. However, therapeutic options for TEC are limited. Chemotherapy cessation, delay, or dose modification are the only reliable methods of resolving TEC. Supportive agents, such as high-potency topical corticosteroids, topical keratolytics, wound care, and pain control, have a variable response. These agents are associated with relatively slow improvement, involving 2 to 4 weeks of recovery after chemotherapy interuption.1

1 June 2020 in JAMA Dermatology
Verified
Journal Article
Open access
PDF file
CNCuong V. Nguyen
Cuong V. Nguyen
KGKevin J. Gaddis
Kevin J. Gaddis
MSMichael R. Stephens
Michael R. Stephens
JSJohn T. Seykora
John T. Seykora
ECEmily Y. Chu
Emily Y. Chu
The widespread use of agrochemicals raises concerns about environmental impacts, particularly on pollinators, such as bees, which serve as bioindicators of contamination. Developing methods to assess contamination risks in bioindicators supports regulatory frameworks, including EU regulations on the maximum residue limits (MRLs) for pesticides in food and the environment. This study presents the development and validation of two complementary analytical methods (LC–MS/MS and IC–HRMS) for highly polar pesticide (HPP) detection and quantification in bee matrices. Both methods were validated according to document SANTE/11312/2021 v2. LC–MS/MS was validated with a limit of quantification (LOQ) of 0.005 mg/kg for all the analytes. Repeatability at 0.005, 0.010, 0.020, and 0.100 mg/kg showed RSDr from 1.6% to 19.7% and recoveries between 70% and 119%. Interlaboratory precision at 0.020 mg/kg across two labs showed RSDR from 5.5% to 13.6%, with recoveries between 91% and 103%. The IC–HRMS method achieved LOQs of 0.01 mg/kg (glufosinate, N-acetyl glufosinate, MPPA, glyphosate, N-acetyl glyphosate, N-acetyl AMPA) and 0.1 mg/kg (fosetyl, phosphonic acid, AMPA), with mean recoveries in repeatability conditions from 84% to 114% and RSDr from 2% to 14%. Intralaboratory precision showed mean recoveries from 87% to 119%, with RSDwR values between 10% and 18%. These methods enable accurate monitoring of HPP contamination, supporting risk assessment and sustainable agriculture.